Skip to main content
. Author manuscript; available in PMC: 2022 Oct 10.
Published in final edited form as: J Control Release. 2021 Sep 2;338:548–556. doi: 10.1016/j.jconrel.2021.08.048

Table 1.

Characterization of SPIO used in the study (average of 3 measurements). Nanoparticle concentration was either measured with NanoSight (large SPIO NW) or calculated theoretically, as described. [28] PDI, polydispersity index. All particle solutions were at 1 mg Fe/mL and had less than 0.2 EU/mL endotoxin as measured with Limulus amebocyte lysate assay.

Particle name Composition Size (intensity weighted), nm PDI Zeta potential, mV
Large SPIO NW 20kDa native dextran, multiple crystals per particle 106 (Z-average), 126 ± 54.42 (peak) 0.16 −7.4 ± 6.8
Small SPIO NW 20kDa native dextran, multiple crystals per particle 67 (Z-average), 81.36 ± 40.35 (peak) 0.22 −6.8 ± 8.8
Ferumoxytol (Feraheme ®) 10kDa reduced carboxymethyl dextran, 1 crystal per particle 26 (Z-average), 26.86 ± 10.53 (peak) 0.27 −15.6 ± 7.4
Ultrasmall SPIO (USPIO) 10kDa reduced T-10 dextran SPIO, 1 crystal per particle 26 (Z-average), 25.96 ± 7.64 (peak) 0.23 −5.0 ± 10.0
Ferumoxtran-10 10kDa native T-10 dextran SPIO, 1-3 crystals per particle 44 (Z-average), 51.19 ± 20.75 (peak) 0.14 −7.2 ± 9.5